Mark A Goldsmith

See Remarks

Mark A Goldsmith (See Remarks) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $18.0M of RVMD (120,000 sh × $150.09, as filed), executed Apr 15.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 12 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$56.3M

shares × price, as filed

Last traded

Sep 16

Filed Sep 18

Median ADV $548.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $64.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 12 filings

Sector per market data · by filing · past 12 months

Most traded names

RVMD

Revolution Medicines, Inc. RVMD · 0 buys · 19 sells 19 filings

Recent filings

RVMDSALE Revolution Medicines, Inc. View filing → $2.7M
13,775 sh × $199.30
Exec Sep 16
Filed Sep 18 · 6:02 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $17.7M
84,644 sh across 10 lots
Exec Aug 21
Filed Aug 25 · 4:06 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $1.6M
10,020 sh × $156.12
Exec Jun 16
Filed Jun 18 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $18.0M
120,000 sh × $150.09
Exec Apr 15
Filed Apr 17 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $1.3M
12,871 sh × $99.48
Exec Mar 17
Filed Mar 19 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $3.3M
32,249 sh across 5 lots
Exec Mar 2
Filed Mar 3 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $1.2M
15,394 sh × $76.82
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $5.0M
66,000 sh across 3 lots
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET More filings →